Stocks · News reference

Watching Edesa Biotech; Zacks Small-Cap Research Gives Stock $19 Price Valuation

Aug 24, 2026, 2:15 PMBenzinga Newsdesk

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 24, 2026, 2:15 PM
Checked: Aug 24, 2026, 2:15 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 20, 2026, 1:15 PMBenzinga Newsdesk
Edesa Biotech shares are trading lower after the company announced the pricing of its $25 million proposed public offering of 3,870,500 shares and warrants at a $5.50 combined price.
Read original at benzinga
EDSA
BenzingaAug 20, 2026, 12:06 PMBenzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Circle8 Group (NASDAQ:CIRC) shares increased by 18.2% to $0.77 during Thursday's pre-market session. The company's market cap stands at $60.1 million. The company's, Q2 earnings came out yesterday.
Read original at benzinga
BIVI CIRC EDSA HYPD IVF
BenzingaAug 20, 2026, 5:28 AMBenzinga Newsdesk
Reported Earlier, Edesa Biotech Prices $25.0M Public Offering Of 3,870,500 Common Shares Plus Warrants At $5.50 Combined Price
Read original at benzinga
EDSA
BenzingaAug 20, 2026, 10:20 AMAkanksha Bakshi
Edesa Biotech Stock Sinks After Fresh Capital Raise
Edesa Biotech Stock falls in premarket trading as investors weigh a $25 million offering, new warrants and potential dilution.
Read original at benzinga
EDSA